Edition:
India

Elanco Animal Health Inc (ELAN.N)

ELAN.N on New York Stock Exchange

23.75USD
5 Jun 2020
Change (% chg)

$1.22 (+5.41%)
Prev Close
$22.53
Open
$23.34
Day's High
$24.14
Day's Low
$23.08
Volume
1,151,250
Avg. Vol
1,197,513
52-wk High
$35.46
52-wk Low
$15.17

Select another date:

Thu, May 7 2020

BRIEF-Elanco Animal Health Reports Q1 Adjusted Earnings Per Share $0.13

* Q1 REVENUE $657.7 MILLION VERSUS REFINITIV IBES ESTIMATE OF $718.4 MILLION

BRIEF-Elanco Expands Executive Team To Lead Company Post Bayer Animal Health Acquisition

* ELANCO EXPANDS EXECUTIVE TEAM TO LEAD COMPANY POST BAYER ANIMAL HEALTH ACQUISITION

BRIEF-Elanco Animal Health Submits Form Co To European Commission

* ELANCO ANIMAL HEALTH SUBMITS FORM CO TO EUROPEAN COMMISSION

BRIEF-Elanco, Vetnow Collaborate To Expand Access To Veterinary Care

* ELANCO, VETNOW COLLABORATE TO EXPAND ACCESS TO VETERINARY CARE, RELIEVE IMPACT OF COVID-19 Source text for Eikon: Further company coverage:

BRIEF-Elanco Animal Health Says CEO Jeffrey Simmons 2019 Total Compensation Was $15.8 Mln Versus $5.4 Mln In 2018

* ELANCO ANIMAL HEALTH SAYS CEO JEFFREY SIMMONS 2019 TOTAL COMPENSATION WAS $15.8 MILLION VERSUS $5.4 MILLION IN 2018 - SEC FILING

BRIEF-UK's CMA Invites Comments On Dechra Pharmaceuticals, Elanco Animal Health

* UK'S CMA INVITES COMMENTS ON ANTICIPATED ACQUISITION BY DECHRA PHARMACEUTICALS PLC OF OSURNIA BUSINESS OF ELANCO ANIMAL HEALTH INCORPORATED

BRIEF-Elanco Animal Health Withdraws Its Previously Announced 2020 Revenue And EPS Guidance

* ELANCO ANIMAL HEALTH INC - WITHDRAWING ITS PREVIOUSLY ANNOUNCED 2020 REVENUE AND EARNINGS PER SHARE GUIDANCE.

BRIEF-Elanco Signs Agreement With Merck Animal Health To Divest Worldwide Rights For Vecoxan

* PRESS RELEASE - ELANCO SIGNS AGREEMENT WITH MERCK ANIMAL HEALTH TO DIVEST WORLDWIDE RIGHTS FOR VECOXAN®

BRIEF-Elanco Animal Health Reports Q4 Loss Per Share Of $0.03

* ELANCO ANIMAL HEALTH REPORTS 2019 FOURTH QUARTER AND FULL YEAR RESULTS

Select another date: